Aria Pharmaceuticals (Series A+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$90,000,000
Company Info
Founders
Andrew Radin
Market
Healthcare & Wellness
Coinvestors
OS Fund,SoftBank,Andreessen Horowitz
Company Description

A preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases; the company's refined drug discovery approach purportedly saves as much as 3 years in drug development and increases success rates 30X vs. traditional methods. Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.